10-Q: AmeriCann Inc. Reports Q2 2024 Results: Revenue Declines Amidst Lease Termination

AmeriCann, Inc. reported a net loss for the second quarter of 2024, with a decrease in revenue primarily due to reduced tenant sales, and announced the termination of a key lease agreement.

Summary

• AmeriCann, Inc. reported a net loss of $166,091 for the three months ended March 31, 2024, compared to a net income of $86,622 for the same period in 2023.
• The company's revenue decreased to $453,655 for the quarter, down from $748,406 in the prior year, primarily due to a decline in tenant sales at the Massachusetts Cannabis Center (MCC).
• For the six months ended March 31, 2024, AmeriCann reported a net loss of $338,090, compared to a net income of $109,367 for the same period in 2023.
• Total revenue for the six months was $929,284, a decrease from $1,483,172 in the previous year.
• The company's operating expenses totaled $1,014,328 for the six months ended March 31, 2024, compared to $992,486 in the prior year.
• AmeriCann's cash and cash equivalents decreased from $1,135,006 on September 30, 2023, to $513,447 on March 31, 2024.
• A significant development was the mutual agreement to terminate the lease with BASK, effective August 31, 2024, after which AmeriCann intends to operate the building as a cannabis cultivation and manufacturing facility.
• BASK will transfer its provisional Cultivation and Product Manufacturing licenses to AmeriCann, with a credit of $40,000 for each license, contingent upon approval from the Massachusetts Cannabis Control Commission.
• The company's total assets decreased from $15,154,894 on September 30, 2023, to $14,788,169 on March 31, 2024.

Sentiment

Score: 3

Explanation: The document indicates a significant downturn in financial performance, a lease termination, and concerns about the company's ability to continue as a going concern. The sentiment is negative due to the financial losses and operational challenges.

Positives

• AmeriCann will gain control of the Building 1 facility at the MCC after the lease termination with BASK, allowing them to operate it directly.
• The transfer of provisional Cultivation and Product Manufacturing licenses from BASK will enable AmeriCann to expand its operations.
• The company has extended the maturity date of a $4,500,000 loan to August 31, 2024, providing additional financial flexibility.
• AmeriCann has a 15-year triple net lease on the land at the MCC, providing long-term control of the property.

Negatives

• AmeriCann experienced a significant decrease in revenue and a shift to a net loss for both the three and six-month periods ending March 31, 2024.
• The company's cash position has significantly decreased, raising concerns about its ability to fund operations and expansion.
• The termination of the lease with BASK, while providing operational control, also indicates potential issues with the tenant's performance.
• The company has an accumulated deficit of $20,191,534 as of March 31, 2024, raising concerns about its long-term financial viability.
• The company's internal controls over financial reporting were deemed ineffective.

Risks

• The company's ability to continue as a going concern is dependent on its ability to generate additional revenues and raise additional funds.
• The company's cash position may not be sufficient to support daily operations, requiring additional financing.
• The company faces risks associated with the cannabis industry, including regulatory changes and market competition.
• The company's internal control over financial reporting is not effective, which could lead to errors in financial reporting.
• The company's accumulated deficit of $20,191,534 raises concerns about its long-term financial stability.

Future Outlook

AmeriCann plans to operate Building 1 at the MCC directly after the lease termination with BASK, focusing on cannabis cultivation and manufacturing. The company may replicate its brands, technology, and innovations developed at the MCC project to additional markets. The company will need to raise additional funds for the expansion of the MCC.

Management Comments

• Management believes that the actions presently being taken to further implement its business plan and generate additional revenues provide the opportunity for the Company to continue as a going concern.
• Management may raise additional funds through the sale of its securities or borrowings from third parties.

Industry Context

The cannabis industry is highly competitive and subject to regulatory changes. AmeriCann's move to operate its own facility reflects a trend of companies seeking greater control over their supply chain and operations. The termination of the lease with BASK may indicate challenges in the current market environment for cannabis operators.

Comparison to Industry Standards

• The decrease in revenue and shift to a net loss is concerning, as many cannabis companies are focused on growth and profitability.
• The company's cash position is weak compared to other companies in the industry, which may limit its ability to expand and compete.
• The termination of the lease with BASK is unusual, as most cannabis companies seek long-term lease agreements to secure their operations.
• The company's internal control weaknesses are a significant concern, as most public companies have robust internal controls to ensure accurate financial reporting.
• Compared to companies like Innovative Industrial Properties (IIP) which focus on leasing properties to cannabis operators, AmeriCann's move to operate its own facility is a different approach.

Related Party Transactions

• The company leases its office space from Strategic Capital Partners, LLC (SCP), a related party.
• The company has a note payable to SCP, a related party, with an outstanding principal of $581,646 as of March 31, 2024.
• The company incurred consulting expenses with SCP.

Stakeholder Impact

• Shareholders will be negatively impacted by the company's net loss and decreased cash position.
• Employees may be affected by the company's financial challenges and operational changes.
• Customers of BASK may experience changes in product availability or service.
• Creditors may be concerned about the company's ability to repay its debts.
• Suppliers may be impacted by the company's financial challenges.

Next Steps

• AmeriCann will take over operations of Building 1 at the MCC after August 31, 2024.
• The company will seek approval from the Massachusetts Cannabis Control Commission for the transfer of licenses from BASK.
• AmeriCann will need to secure additional funding for the expansion of the MCC.
• The company will need to remediate the material weaknesses in its internal control over financial reporting.

Key Dates

Keywords

cannabis, cultivation, manufacturing, lease, revenue, financial results, Massachusetts Cannabis Center, AmeriCann, BASK, licenses